DCF — SOUTHERN TENNESSEE MEDICAL CENTER
Enterprise Value: $54.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$54.0M
Enterprise Value
$12.9M
PV of Cash Flows
$41.1M
PV of Terminal Value
$66.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $120.0M | $8.2M | 7.0% | $1.8M | $1.7M |
| Year 2 | $123.6M | $9.7M | 8.0% | $2.8M | $2.3M |
| Year 3 | $127.3M | $11.3M | 9.0% | $3.8M | $2.9M |
| Year 4 | $131.2M | $12.2M | 9.0% | $4.5M | $3.0M |
| Year 5 | $135.1M | $13.0M | 10.0% | $4.8M | $3.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $54.0M. Terminal value accounts for 76% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$116.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.06335624231629663
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5